Filing Details
- Accession Number:
- 0001567619-19-000988
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2019-01-10 18:50:52
- Reporting Period:
- 2019-01-08
- Accepted Time:
- 2019-01-10 18:50:52
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1048477 | Biomarin Pharmaceutical Inc | BMRN | Pharmaceutical Preparations (2834) | 680397820 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1221590 | Jacques Jean Bienaime | C/O Biomarin Pharmaceutical Inc. 770 Lindaro St. San Rafael CA 94901 | Chief Executive Officer | Yes | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Acquisiton | 2019-01-08 | 6,000 | $14.39 | 294,290 | No | 4 | M | Direct | |
| Common Stock | Disposition | 2019-01-08 | 1,000 | $91.14 | 293,290 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-08 | 1,599 | $91.55 | 291,691 | No | 4 | S | Direct | |
| Common Stock | Disposition | 2019-01-08 | 3,401 | $91.73 | 288,290 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | M | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct | |
| No | 4 | S | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| Common Stock | Stock Option (Right to buy Common Stock) | Disposition | 2019-01-08 | 6,000 | $0.00 | 6,000 | $14.39 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 83,000 | 2009-11-12 | 2019-05-11 | No | 4 | M | Direct |
Reported Non-Derivative Holdings
| Sec. Name | Remaning Holdings | Nature of Ownership | Explanation |
|---|---|---|---|
| Common Stock | 181,501 | Indirect | Shares held by Jean-Jacques Bienaime Family Trust |
Footnotes
- Trade made pursuant to a 10b5-1 plan executed on November 15, 2018.
- The price in column 4 is the weighted average price. The price actually received ranged from $90.51 to $91.45. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- The price in column 4 is the weighted average price. The price actually received ranged from $91.51 to $91.60. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- The price in column 4 is the weighted average price. The price actually received ranged from $91.61 to $92.22. The reporting person shall provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price.
- Reflects the number of options outstanding after the transactions from this specific stock option grant.
Billionaire Hedge Funds
